Venous thromboembolism - Expanding therapeutic options
Venous thromboembolism (VTE) is caused by the formation of blood clots within a vein resulting in vein occlusion and risk of blood clots travelling to the pulmonary arteries. VTE manifestations are deep vein thrombosis (DVT) and pulmonary embolism (PE). Until recently, standard therapy for VTE inclu...
Main Author: | I. A. Filippova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2013-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1210 |
Similar Items
-
Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
by: A. V. Rudakova
Published: (2015-11-01) -
THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT
by: S. R. Gilyarevskiy
Published: (2016-06-01) -
The treatment of venous thromboembolism with new oral anticoagulants
by: Davide Imberti
Published: (2013-12-01) -
EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON
by: V. I. Petrov, et al.
Published: (2016-12-01) -
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
by: Victoria Speed, et al.
Published: (2021-10-01)